PuraPharm Corporation Limited (01498)

DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Chan Abraham Yu Ling02-Dec-11Ch, CEO, Fdr
Chan Charmayne31-Jul-2118-Jul-26CoSecDue to the need of devoting more time to her other business commitments and work arrangements.
18-Jul-26AuRepDue to the need of devoting more time to her other business commitments and work arrangements.
Chan Eddie Kin Man01-Sep-2028-May-21NED
15-Nov-1701-Sep-20ED
02-Dec-1115-Nov-17NED
Chan Eugene Kin Keung12-Jun-1528-May-21INED
Chan Lung Sang22-Aug-1625-May-18ED
Chan Man Viola Yee Wai02-Dec-11ED
Cheng Frederick Hok Kai16-Apr-1001-Feb-18CoSec
Cheong Shin Keong28-Jun-2131-Mar-22NEDDue to expiry of his term of service under his letter of appointment as the non-executive Director of the Company
01-Sep-2028-Jun-21ED
24-Mar-2001-Sep-20NED
Chow Stanley28-Aug-1823-May-22NEDNo reasons provided
23-May-22MbCCNo reasons provided
Chu Dickson Pui Ki18-Jul-26CoSec, AuRep
Ho George Kwok Wah12-Jun-1504-Jul-25INEDResigned to devote more time to develop his personal and other business commitments.
Ho Kwok Wah, George04-Jul-25MbCC, MbNCResigned to devote more time to develop his personal and other business commitments.
Kam Biu Tsoi, Alvin30-Jun-25ED
Lau Ka Kuen24-Sep-1831-Jul-21CFO, CoSec
01-Feb-1824-Sep-18CoSec, FC
Lee Stephen27-Apr-26INED, MbAC, MbCC, MbNC
Leung Chin Man22-Apr-1422-Aug-16MD
Leung Lim Kin Simon30-Jun-25MbNC
Leung Simon Lim Kin12-Jun-15INED
Leung Stephen Kwok Keung14-Jun-23NED
Li Wai Shan24-Sep-18CFO
Ng Charles Wang Wai27-Apr-26INED, MbAC, MbCC, MbNC
Norimoto Hisayoshi17-Nov-2020-Nov-23EDHis three years’ term of office under the service agreement entered into between the Company and Dr. Norimoto had expired
Tsoi Alvin Kam Biu02-Dec-1128-May-21V-Ch
Tsui Lap Chee12-Jun-1525-Jun-26INEDProf. Tsui tendered his resignation to support the renewal and succession of the Board, taking into account the new requirement under the Listing Rules on long-serving independent non-executive Directors.
25-Jun-26MbAC, MbCC, MbNCProf. Tsui tendered his resignation to support the renewal and succession of the Board, taking into account the new requirement under the Listing Rules on long-serving independent non-executive Directors.